Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 June 2023 to Question 186946, on Yellow Card Scheme, when data collection began on medical devices which will be made available in a format similar to that of the Innovative Devices Access Pathway.

In 2015, the Medicines and Healthcare products Regulatory Agency (MHRA) simplified its medicine and device incident report systems by extending the Yellow Card scheme to collect reports on medical device incidents in addition to suspected adverse drug reactions (ADRs). The MHRA's interactive Drug Analysis Profiles contain listings of all suspected ADRs reported through the Yellow Card scheme for medicines. MHRA is currently working to improve the Yellow Card reporting site and this work includes enhanced data visualisations of incident reports, and this will be rolled out across all medicinal products, including medical devices. This work will continue through 2023.